Recifercept (TA-46) is a recombinant human soluble fibroblast growth factor receptor 3, a decoy protein that competes for the ligand of mutant FGFR3.Recifercept is used in the study of chondrodysplasia because it restores normal bone growth by preventing negative inhibitory signaling of mutant FGFR3 in patients with pediatric chondrodysplasia.Recifercept is a recombinant human recombinant fibroblast growth factor receptor 3 that competes for the ligand of mutant FGFR3.

Ibritumomab tiuxetan (IDEC-129) is an antibody targeting CD20, conjugated to a radioactive isotope via a chelating agent Tiuxetan, and can be used in radioimmunotherapy.

Alunacedase alfa (APN-01) is a soluble angiotensin-converting enzyme 2 (hrsACE2) with antiviral activity that reduces the competitive entry of SARS-CoV-2 into cell membranes bound to ACE2. alunacedase alfa mimics ACE2 in vivo and can be used to study novel coronavirus infections, pulmonary hypertension and acute lung injury. Alunacedase alfa mimics ACE2 in vivo and can be used to study novel coronavirus infections, pulmonary hypertension and acute lung injury.

Inpegsomatropin is a long-acting recombinant human growth hormone that has been pegylated.

Alacizumab pegol (CDP-791), a pegylated antibody fragment targeting KDR, is utilized in cancer research [1].

Zolimomab aritox (H65-RTA) is a complex immunocoupling agent that connects a monoclonal antibody (H65) targeting the pan-T-cell antigen CD5 with the ribosomal inhibitory protein ricin (RTA). This compound demonstrates anticancer properties and is applicable in research on cutaneous T-cell lymphoma [1].

Palsucibep pegol is an engineered protein that specifically binds to human lipocalin-2. It also targets hepcidin [1].

Peginterferon alfacon-2 is a human antibody targeting IFNAR1/2 [1].

Epoetin beta (rhEPO), a recombinant erythropoietin, is crucial for sustaining erythropoiesis and is utilized in anemia research [1].

Clivatuzumab tetraxetan (IMMU107), a humanized anti-MUC1 monoclonal antibody, exhibits anti-tumor activity and holds potential for research in metastatic pancreatic cancer [1] [2].

Cepeginterferon alfa-2b, a pegylated interferon, features a polyethylene glycol (PEG) base with a molecular weight of 20 kDa. This compound is utilized in the research of numerous diseases, including hepatitis C virus (HCV), polycythemia vera (PV), and essential thrombocythemia (ET) [1] [2].

Efpegsomatropin is an active peptide that can be used for various biochemical studies.

Cetuximab sarotalocan (Cetuximab-IRDye-700DX) is a conjugate comprising Cetuximab, an anti-EGFR monoclonal antibody, and IRdye700DX, a near-infrared photosensitizing dye. It is utilized in the study of head and neck cancers [1] [2].

Eflapegrastim, a humanized IgG4 monoclonal antibody and granulocyte colony-stimulating factor (G-CSF), targets the G-CSF receptor (c-Fms). It promotes the proliferation and differentiation of neutrophil progenitor cells, ensuring a stable count of mature and functional neutrophils, and effectively shortens the duration of neutropenia [1].

Alvircept sudotox, a recombinant CD4 fused with exotoxin A from Pneumonas aeruginosa, is utilized in HIV infection research [1].